Renal/Genitourinary Flashcards
Describe the parasympathetic, sympathetic and somatic innervation to the bladder respectively
pelvic nerve, hypogastric plexus, pudendal nerve
LUTS (lower urinary tract symptoms) associated with storage
urgency, frequency, nocturia, overflow incontinence
LUTS (lower urinary tract symptoms) associated with voiding
poor intermittent stream, hesitancy, incomplete emptying, post micturition dribbling, straining
What is serum prostate specific antigen (PSA)?
A glycoprotein that is expressed by normal and neoplastic prostate tissue, produced to form the fluid in semen
In what cases is PSA raised?
BPH, prostate cancer, perianal trauma, taller men, recent ejaculation, UTI, prostatitis
What does a PSA of >1.4ng/ml indicate?
increased risk of LUTS progression (e.g. acute urinary retention)
Causes of acute urinary retention?
prostatic obstruction (e.g. BPH, prostate cancer), urethral strictures, alcohol, constipation, post-op, infection
Cause of chronic urinary retention?
prostatic enlargement due to BPH or prostate cancer
Treatment for acute urinary retention?
catheter, alpha-1 blockers to help relax smooth muscle in the bladder neck
What should be considered in any patient with renal impairment?
urinary tract obstruction
3 classifications of urinary tract obstruction?
luminal, mural and extra-mural
Diagnosis of urinary tract infection
- specific location of pain
- Bloods - U&Es and creatinine raised
- Urinary sample
- Ultrasound
Treatment for lower tract urinary obstruction?
urethral or suprapubic catheter
Advantages of a suprapubic catheter vs a urethral
- Less risk of urethral damage and UTI
2. Less likely to be colonised by bacteria in the long-term
Treatment for upper tract urinary obstruction?
Nephrostomy
What is benign prostatic hyperplasia (BPH)?
increase in the size of prostate without the presence of malignancy
What is the prostate?
Accessory gland in the male reproductive system, secretes 70% of the volume of seminal fluid and is hormone dependent, found just below the bladder with the urethra running through it
Epidemiology of BPH?
common, affects 24% of men aged 40-65, 40% of men >65, affects Afro-Caribbeans more severly than white men
What procedure to the testicles is protective of BPH? why?
castration, lack of androgens, testosterone does not cause BPH but is required for BPH
Clinical presentation of BPH?
frequency of micturition, nocturia, delay in initiation of micturition, post-void dribbling, acute urinary retention
Pathophysiology in BPH?
Benign proliferation of inner layers of prostate, gets bigger, squeezes and may partially block the urethra –> urinary problems
Diagnosis of BPH?
digital rectal exam (feel enlarged and smooth prostate), serum electrolytes and renal ultrasound, serum PSA (may be raised), biopsy and endoscopy
In BPH, how might the prostate feel upon rectal examination?
Enlarged and smooth
Lifestyle management of BPH?
decrease alcohol, caffeine
Drugs to treat BPH?
- Alpha-1 antagonists e.g. tamsulosin to relax smooth muscle in bladder and increase urinary flow
- 5-alpha reductase inhibitor e.g. finasteride as it blocks the conversion of testosterone to dihydrotestosterone (androgen responsible for prostatic growth)
Kidney cancer - most common form
renal cell carcinoma
Epidemiology of renal cell carcinoma
Males > females, average age 55
Clinical presentation of renal cell carcinoma
haematuria, loin/lumbar pain, mass in flank, malaise, weight loss, fever
Investigations for renal cell carcinoma
Ultrasound, CT scan, MRI - staging, renal biopsy
Management of renal cell carcinoma?
localised disease - nephrectomy
metastatic disease - interleukin-2 and interferon lead to remission
bladder/urothelial cancer - most common type of which type of carcinoma?
transitional cell carcinoma
Epidemiology for bladder/urothelial cancer?
males > females, av age 80
Clinical presentation of bladder/urothelial cancer
Painless haematuria, recurrent UTIs, voiding irritability
Investigations for bladder/urothelial cancer?
Cytoscopy and biopsy (diagnostic), CT for staging, urinary tumour markers
management for bladder/urothelial cancer?
cystectomy, surgical resection, chemotherapy
Risk factors for prostatic cancer?
FHx, increasing age, genetic predisposition (HOXB13 gene)
Hormonal factors –> prostatic cancer
increased testosterone
Clinical presentation of prostatic cancer
bladder outflow obstruction, gland hard and irregular (rectal examination), symptoms due to metastases e.g. bone
Investigations for prostatic cancer
transrectal ultrasound and biopsy (diagnostic), digital rectal exam, elevated serum PSA
Management for prostatic cancer
Prostatectomy, removal of androgenic drive e.g. bilateral orchidectomy, antiandrogens
Risk factors for testicular cancer?
Undescended testes, FHx, infertility
Clinical presentation for testicular cancer?
painless lump in testes, testicular/abdominal pain, symptoms due to metastases
Investigations for testicular cancer?
Ultrasound, serum concentration of tumour markers
Management of testicular cancer
orchidectomy, chemotherapy
What is chronic kidney disease?
abnormal kidney function/structure for > 3 months with health implications
Epidemiology for CKD?
Risk of CKD increased with age, females > males, often co-exists with CVD and diabetes
Classification of CKD?
- Based on GFR category
- Presence of albuminuria
- Cause of kidney disease
stage 1 CKD
Normal GFR >90ml/min/1.73m^2
What are mesangia lcells
Specialised cells that provide structural support to the glomerular tuft
Causes of CKD?
diabetes, glomerulonephritis, HTN, atherosclerotic renovascular disease, acute renal failure
Risk factors for CKD?
DM, HTN, old age, CVD, renal stones, BPH, recurrent UTIs, SLE, proteinuria, AKI, smoking, chronic use of NSAIDs
Presentation of CKD?
Early stages often asymptomatic (discovered by chance on routine blood/urine test), nausea, vomiting, diarrhoea, fatigue, weight loss, nocturia, polyuria, symptoms due to salt retention (oedema), sexual dysfunction
Complications of CKD?
- Anaemia - due to reduced EPO production by diseased kidney
- Bone disease - impaired 1,25-hydroxy vit D production
- Neurological - autonomic dysfunction –> postural hypotension
- CVD - occurs due to increased frequency of HTN
Pathophysiology of CKD?
Irreversible nephron loss, same burden of filtration spread across less nephrons –> nephron failure
ECG investigation for CKD?
for high K+
CKD urinalysis investigation?
Haematuria, proteinuria, albumin:creatinine ratio
CKD investigations - bloods
Raised phosphate and low calcium, low Hb
CKD investigations - serum biochemistry
high urea and creatinine, raised ALP, raised PTH
Diagnostic investigation for CKD?
Biopsy and histology
Management of CKD
Treatment of underlying disease, treatment to slow renal progression (tight glucose control and ACE-i/ARBs), treatment of renal complications of CKD (e.g. anaemia, oedema), treatment of other complications of CKD, prepare for renal replacement therapy
Nephrosis
proteinuria due to podocyte pathology
Nephritis
haematuria due to inflammatory damage
3 broad categories of glomerulonephritis?
- Conditions that damage the glomerular permeability barrier
- Conditions that produce severe necrotising glomerular injury
- Conditions associated with glomerular inflammation, with mesangial/subendothelial immune deposits
Conditions that damage the glomerular permeability barrier
produce proteinuria (nephrotic syndrome) - minimal change disease, membranous GN
Conditions that produce severe necrotising glomerular injury
cause leakage of blood (haematuria) and protein (proteinuria) into urine, reduced GFR, leads to acute renal failure, crescentic morphology - vasculitis, anti-GBM disease, PGN
Crescentic GN
Crescents form - a proliferation of cells within Bowman’s space - as a response to capillary rupture with exudation
Conditions associated with glomerular inflammation, in association with mesangial and/or subendothelial immune deposits
Lupus nephritis, IgA nephropathy
Nephrotic syndrome - epidemiology
rare, DM is the most common secondary cause
Tetrad of symptoms for nephrotic syndrome
Proteinuria, hypercholesterolaemia, hypoalbuminaemia, oedema
Proteinuria
> 3.5g/24hr
Pathophysiology of nephrotic syndrome
- Structural and functional abnormalities of podocytes
- Increased filtration of macromolecules across the glomerular capillary wall
- Oedema occurs due to salt retention
Causes of primary nephrotic syndrome
minimal change disease, membranous GN, focal segmental glomerulosclerosis
Minimal change disease
Commonest form of nephrotic syndrome in children, subtle changes to the glomerular morphology on biopsy, steroids induce remission in most
Membranous GN
Histological presence of immune deposits (IgG and C3) on the podocyte side of the GBM with thickening of the capillary wall secondary to production of new BM, most common in adults
Focal segmental glomerulosclerosis
Unknown aetiology, sclerosis that is focal and only affects certain glomeruli
Secondary causes of nephrotic syndrome
DM, amyloidosis, infections (Hep B/C), SLE, RA, malignancy
Diagnosis for nephrotic syndrome
- Renal biopsy to establish cause
- Urine dipstick - proteinuria
- Baseline measurements - albumin, eGFR, glucose
- Serum tests - Anti-AGM antibodies, ANCA
Management for nephrotic syndrome
- reduce oedema - restrict fluid and salt intake, loop diuretics
- reduce proteinuria - ACE-i/ARBs
- Treat underlying cause
- Reduce risk of complications e.g. statins for hyperlipidaemia
Nephritic syndrome
Caused by inflammation to the glomerulus that results in microscopic or macroscopic haematuria, proteinuria and HTN
5 ‘causes’ of nephritic syndrome
- Rapidly progressive GN (RPGN)
- Anti-GBM antibody GN (Goodpasture’s)
- ANCA associated vasculitis
- Immune complex mediated GN
- Membranoproliferative GN
Rapidly progressive GN
Any aggressive GN, rapidly progressing to renal failure (not a disease itself), caused by small vessel vasculitis, lupus nephritis, anti-GBM disease, crescents seen in biopsy due to breaks in BGM allowing influx of inflammatory cells
Anti-GBM antibody GN (Goodpasture’s syndrome)
Autoimmune condition in which the target antigen is on the BM –> production of anti-GBM antibodies –> rapidly progressive GN
In some patients with anti-GBM antibody GN, antibodies bind to the antigens in the BM and to?
alveolar capillary BMs, resulting in pulmonary haemorrhage and haemoptysis
Goodpasture’s syndrome
When RPGN + pulmonary haemorrhage occur
ANCA associated vasculitis
Associated with serum antibodies to neutrophil cytoplasmic antigens - ANCA results in nectrotising glomerulonephritis (not associated with immune complex deposition)
Immune complex mediated GN
Deposition of immune complexes on GBM
Causes of immune complex mediated GN?
IgA nephropathy, post-streptococcal GN, lupus nephritis
IgA nephropathy
Defined by the presence of IgA-dominant glomerular deposits, commonest type of GN
Membranoproliferative GN
Characterised by mesangial cell proliferation and thickening of the capillary walls with duplications of the basement membranes
Presentation of acute nephritic syndrome
Haematuria, proteinuria, HTN and oedema, oliguria
Investigations for nephritic syndrome
Renal biopsy for diagnosis, same as nephrotic syndrome
Causes of congential renal cysts
Genetic mutation leads to predisposition for cyst formation, there is increased abnormal cell proliferation, cyst initiation, fluid secretion by epithelial cells
Causes of renal cysts
acquired over time, CKD, autosomal dominant/recessive polycystic kidney disease
Most common type of polycystic kidney disease?
Autosomal dominant
Causes of ADPKD?
mutation in either the PKD1 (85%) or PKD2 (15%) gene
Pathophysiology of ADPKD
PKD1 and PKD2 encode for the polycystin proteins which are transmembrane proteins which interact to promote the normal development and function of kidneys. The polycystin complex occurs in cilia that are responsible for sensing flow in the tubules, and defective proteins –> defective ciliary signalling –> disorientated cell division –> cyst formation
Clinical presentation of ADPKD?
excessive water and salt loss (causing problems such as nocturia), loin pain, HTN, bilateral kidney enlargement renal colic (due to clots), haematuria, renal stones
Extra-renal manifestations of ADPKD?
Polycystic liver damage, subarachnoid haemorrhage (associated with berry aneurysm formation), pancreatic cysts can cause pancreatitis, male infertility, cardiac abnormalities (mitral valve prolapse)
Diagnosis of ADPKD?
Clinical examination - large irregular kidneys, HTN
Ultrasound - detect cysts
In adults with FHx, criteria for diagnosis:
1. at least 2 renal cysts <30
2. 2 cysts per kidney 30-59
3. 4 cysts per kidney 60+
Management of ADCKD?
No treatment to slow progression, BP control, analgesia to treat stones, laparoscopic removal of cysts to help with pain
Autosomal recessive polycystic kidney disease (ARPKD) - epidemiology?
Less common than ADPKD, disease of infancy and childhood, leads to differing degrees of renal and hepatic involvement
ARPKD - later the manifestation of the renal disease, the…
more marked the liver disease (tend to show opposite degrees of severity)
Clinical presentation of ARPKD?
variable, presents in infancy with multiple cysts and congenital hepatic fibrosis, enlarged polycystic kidneys, kidney failure
Diagnosis of ARPKD
Diagnosed antenatally or neonatally, ultrasound to see cysts, CT and MRI, genetic testing
Treatment for ARPKD?
- No treatment
- Family counselling
- Laparoscopic removal of cysts to alleviate pain
- BP control with ACE-i
- Analgesia for stones
Erectile dysfunction
persistent inability to attain and maintain an erection
Pathophysiology of erectile dysfunction
Neurogenic - failure to initiate
Arteriogenic - failure to fill
Venogenic - failure to store
3 arteries supplying the penis
dorsal, cavernous, urethral
Causes of erectile dysfunction
age, diabetes, coronary artery disease, dyslipidaemia, trauma, drugs, hypogonadism
Examination for erectile dysfunction
height, weight, thyroid exam, pulmonary status, peno-scrotal exam